Evaluation of IFN-λ responsiveness on renal cell carcinoma

被引：0
|
作者：
Kotredes, Kevin [1 ]
Lopez, Yolanda [1 ]
Gamero, Ana [1 ]
机构：
[1] Temple Univ, Dept Biochem, Philadelphia, PA 19122 USA
来源：
CYTOKINE | 2010年 / 52卷 / 1-2期
关键词：
D O I：
10.1016/j.cyto.2010.07.239
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] Transcriptional program associated with IFN-α response of renal cell carcinoma
    Banerjee, D
    Chadalavada, RSV
    Bourdon, V
    Korkola, JE
    Motzer, RJ
    Chaganti, RSK
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2006, 26 (03): : 156 - 170
  • [2] Bevacizumab in combination with IFN-α in metastatic renal cell carcinoma: the AVOREN trial
    Melichar, Bohuslav
    Prochazkova-Studentova, Hana
    Vitaskova, Denisa
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1253 - 1261
  • [3] A phase II trial of temozolomide and IFN-α in patients with advanced renal cell carcinoma
    Sunkara, U
    Walczak, JR
    Summerson, L
    Rogers, T
    Eisenberger, M
    Denmeade, S
    Pili, R
    Huff, CA
    Sinibaldi, V
    Carducci, MA
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2004, 24 (01): : 37 - 41
  • [4] Characterization of the antitumor activities of IFN-α8 on renal cell carcinoma cells in vitro
    Yanai, Y
    Horie, S
    Yamamoto, K
    Yamauchi, H
    Ikegami, H
    Kurimoto, M
    Kitamura, T
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (12): : 1129 - 1136
  • [5] Advanced renal cell carcinoma in which a combination of IFN-α and meloxicam was thought to be effective
    Yoshino, S
    Okabe, T
    INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (01) : 52 - 55
  • [6] A randomized phase II/III study of naptumomab estafenatox plus IFN-α versus IFN-α in advanced renal cell carcinoma.
    Hawkins, Robert E.
    Gore, Martin Eric
    Shparyk, Yaroslav
    Bondar, Vladimir
    Gladkov, Oleg
    Ganev, Tosho
    Harza, Mihai
    Polenkov, Serhii
    Bondarenko, Igor
    Karlov, Petr A.
    Karyakin, Oleg
    Khasanov, Rustem
    Hedlund, Gunnar Eric
    Forsberg, Goran
    Nordle, Orjan
    Eisen, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] TOCILIZUMAB CAN ENHANCE THE ANTI-TUMOR EFFECT OF IFN-α IN RENAL CELL CARCINOMA
    Oguro, T.
    Ishibashi, K.
    Sugino, T.
    Kumagai, S.
    Takahashi, N.
    Haga, N.
    Yanagida, T.
    Aikawa, K.
    Yamaguchi, O.
    Kojima, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 69 - 69
  • [8] IFN-α cannot substitute lack of IFN-γ responsiveness in cells of an IFN-γR1 deficient patient
    van de Wetering, Diederik
    van Wengen, Annelies
    Savage, Nigel D. L.
    van de Vosse, Esther
    van Dissel, Jaap T.
    CLINICAL IMMUNOLOGY, 2011, 138 (03) : 282 - 290
  • [9] Reduced number of IFN-γ producing cells in peripheral blood is a biomarker for patients with renal cell carcinoma
    Wu, Kun-Jin
    Yang, Kun
    Zhang, Feng-Ping
    Liu, Si-Nan
    Yang, Kai-Bo
    Ma, Xiao-Hua
    Zhang, Xing
    Ma, Yan-Fen
    Geng, Hui
    Wang, Zheng
    Liu, Chang
    Lin, Ting
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (07)
  • [10] COmparative analysis of responsiveness to IFN-α and IFN-λ by normal human bronchial epithelial cells and hepatocytes
    Dickensheets, Harold
    Sheikh, Faruk
    Pos, Zoltan
    Marincola, Francesco
    Donnelly, Raymond P.
    CYTOKINE, 2010, 52 (1-2) : 34 - 34
12345